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Smoking alters the phenotype of macrophages in 
induced sputum 
C. LENSMAR’, G. ELMBERGER’, M. SK~LD* AND A. EKLUND” 
“Department of Medicine, Division of Respirafory Medicine, Karolinska Hospital, Stockholm, 
Sweden 
‘Department of Pathology, Division of Cyfology, Karolinska Hospifal, Stockholm, Sweden 
To investigate the effect of chronic smoke exposure on pulmonary macrophages (PM), the expression of seven 
different surface and intracellular molecules of PM was studied in induced sputum (IS) samples from healthy 
volunteers -nine smokers and seven non-smokers. Sputum was induced by inhalation of nebulized saline (3.5% 
NaCl). Cell viability and total cell counts (TCC) were performed immediately. Cell differentials were determined on 
May-Grtinwald Giemsa-stained cytospin preparations. The PM were immunologically characterized by use of the 
following monoclonal antibodies: RFDl, RFD7, CD1 lb, CD54, CD68, CD71 and HLA-DR. The stainings were 
performed with a three-step, indirect immuno-alkaline phosphate method. Viability and TCC did not differ between 
the groups. Smokers had a higher percentage of macrophages (PcO.05) and a lower proportion of neutrophils 
(P<O.OS). The percentage of macrophages expressing RFDl, HLA-DR, CD71 (P<O.Ol for all) and CD54 (PcO.05) 
was significantly lower in smokers, whereas the remaining markers were expressed equally in the two groups. The 
results indicate that smoking induces a decrease in the expression by PM of surface molecules known to be 
associated with the antigen-presenting function. 
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Introduction 
The pulmonary macrophage (PM) population is phenotypi- 
tally and functionally heterogeneous. Some PM exhibit an 
effector cell phenotype, possessing a phagocytic and micro- 
bicidal capacity (1). Others have immunoregulatory func- 
tions, acting as antigen-presenting cells (2) or suppressor 
macrophages, performing an immunosuppressive function 
by inhibiting the proliferative capacity of T-cells in the 
normal lung (3,4). Leukocyte migration, homing, and cell- 
cell interaction is dependent partly on various adhesion 
molecules, among which the leukocyte adhesion molecules 
(LeuCAM; CDll/CD18), which belong to the struc- 
tural family of integrins and the immunoglobulin-related 
intercellular adhesion molecules (ICAM), are essential (5). 
Previous investigators have studied the effects of cigarette 
smoke on macrophages in bronchoalveolar lavage (BAL) 
fluid, showing numerous morphological and functional 
changes. Smokers have a higher number of alveolar 
macrophages (AM) in their BAL fluid compared to non- 
smokers, indicating an increased influx to and/or decreased 
clearance of AM from the distal airways (6). Smokers’ 
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macrophages are larger, show cytoplasmic inclusions and 
autoimmunofluorescence (6,7) and produce higher levels of 
oxygen radicals and lysosomal enzymes (7-9). Studies of 
changes in the immunophenotype of smokers’ macrophages 
have, however, produced somewhat inconsistent results. It 
has been shown that LeuCAMs are expressed differently in 
AM from smokers and non-smokers. Some investigators 
have reported a decreased proportion of CD1 l/CD18- 
positive AM in smokers (10,l l), while others have reported 
an increase compared with non-smokers (8). 
Contradictory results have also been achieved in studies 
of the expression of HLA class II surface antigens on AM 
in BAL. Using different methods, some investigators have 
shown a reduction of HLA antigen density on AM in 
smokers compared to non-smokers (11,12), whereas 
others have found a similar expression of HLA in the 
groups (6,8). 
BAL allows collection of material from the distal air- 
ways, but is a laborious method unsuitable for frequent 
studies in the same subject. An alternative method of 
collecting material from the airways is induced sputum (IS), 
a non-invasive procedure that can be performed repeatedly. 
In this study we aimed to explore the possibility of showing 
smoking-induced changes in the immunophenotype of 
pulmonary macrophages in IS material. We investigated 
macrophage-associated intracellular and surface antigens in 
IS from smokers and non-smokers in order to identify any 
difference in expression between the groups. 
0 1998 W. B. SAUNDERS COMPANY LTD 
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Methods 
SUBJECTS 
Sputum samples were collected from 16 healthy volunteers, 
nine smokers (one man and eight women, 21-38 years) and 
seven non-smokers (one man and six women, 2146 years). 
The subjects showed no signs of infection. In the non- 
smoker group, four never had been smokers and three had 
stopped smoking for at least 5 yr. The cigarette consump- 
tion of the smokers was 7.5 (4.9-8.3) pack-years (median, 
lower and upper quartiles), and the median present con- 
sumption at least 1.5 cigarettes day - ’ for the last 5 yr. The 
study had the approval of the local Ethics Committee, and 
informed consent was obtained. 
SPUTUM INDUCTION AND PROCESSING 
After administration of 2OOpg salbutamol (Ventoline@, 
Glaxo, U.K.), sputum was induced by inhalation of 3.5% 
sterile solution (Apoteksbolaget, Sweden). The saline was 
nebulized with an ultrasonic nebulizer (De Vilbiss Ultraneb 
2000, U.S.A.) and inhaled for up to 20 min. After 5 min, 
and at subsequent intervals of 3-5 min, subjects were asked 
to rinse their mouths and try to cough sputum into clean 
plastic tubes. The first and third expectorates were pooled 
and stored for future analysis, and the second expectorate 
was collected in a separate tube for use in cell analysis. The 
volume of the sputum sample was determined, and 5 ml of 
the material was diluted with 0.1 ml 10% dithiothreitol 
(DTT, Sigma, MO) and 1.9 ml Hank’s balanced salt solu- 
tion (HBSS, Sigma), gently mixed and incubated until 
homogenized. The sample was centrifuged at 800 rpm for 
10 min and the cell pellet was resuspended in l-2 ml HBSS. 
Fifty microlitres of the cell suspension was used to assess 
viability by trypan blue cell exclusion and to determine the 
total cell count in a Btirker chamber. Cytospins were 
prepared using aliquots of cell suspension equivalent to 
60 000 cells per slide. The material was centrifuged at 
800 rpm for 6 min in a Shandon cytocentrifuge (Cytospin 2, 
Shandon, U.K.). Two slides were stained using May- 
Griinwald Giemsa for differential cell counts and the rest 
stored at - 70°C until further processed. 
IMMUNOCYTOLOGICAL STAININGS 
The stainings were performed using a three-step, indirect 
immuno-alkaline phosphatase (ALP) method. Frozen slides 
were warmed to room temperature before processing. Slides 
were fixed in - 20°C acetone for 10 min and rehydrated in 
tris-buffered saline (TBS), pH 7.6 for 5 min. The slides were 
subsequently incubated with 0.07 ml of the appropriate 
dilutions of primary monoclonal antibodies (Table l), 
ALP-conjugated rabbit anti-mouse antibody (DAKO, 
Denmark) and ALP-conjugated swine anti-rabbit antibody 
(DAKO), in humid chambers for 30 min each, and carefully 
washed with TBS between the steps. The immunological 
reaction was visualized using freshly prepared ALP sub- 
strate (Phosphatase Fast Red Sigma solution, Sigma) 
containing 1 mmol 1~ ’ of levamisole (Sigma) to inhibit 
endogenous ALP activity. The enzyme-substrate reaction 
was interrupted with tap water and the slides were counter- 
stained with haematoxylin for 30 s, blued in tap water and 
air-dried. For mounting, a glycerine mountant (Merck, 
Germany) was used. The slides were viewed with a light 
microscope (Nikon, Japan). Macrophages were identified 
on the basis of morphological features, and positive cells 
were recognized by red staining (Plate 1). A minimum of 
600 cells were counted by two independent observers, and 
the mean value of the two observations was used. An 
irrelevant monoclonal antibody (MNF116, Anti-human 
cytokeratin, DAKO) was used as negative control). 
STATISTICAL ANALYSIS 
The data are presented as medians with upper and lower 
quartile values. Statistical comparisons were made using the 
non-parametric Mann-Whitney U test. A P value ~0.05 
was considered as significant. 
Results 
TOTAL AND DIFFERENTIAL CELL COUNTS 
The results are expressed as medians with upper and lower 
quartiles. The cell viability and total cell count did not differ 
significantly between smokers and non-smokers (Table 2). 
Smokers had a higher percentage of macrophages, 69.4 
(51.475.9)%, compared with non-smokers, 36.4 (26.7- 
48.4)%, (P<O.O5), and a lower percentage of neutrophils, 
29.6 (14.7-36.4)%, compared with 63.4 (49.7-66.4)%, 
(P<O.O5). 
The percentage of lymphocytes and eosinophils did not 
differ significantly between the groups (Table 2). 
IMMUNOCYTOLOGICAL STAININGS OF 
MACROPHAGES 
The results are expressed as the percentage of positive cells 
showing the morphological characteristics of PM (Table 3). 
Plate 1 shows a picture of PM recovered with IS, stained for 
HLA II. The percentage of PM expressing the RFD1 and 
HLA class II molecules was significantly lower in smokers, 
57.0 (42.G62.5)% and 93.0 (84.&95.0)% respectively, 
compared with non-smokers, 86.0 (76.c89.0)% and 100 
(loo)%, (P<O.Ol both, Fig. 1). The expression of CD54 by 
smokers’ PM, 33.0 (14.043.0)%, was lower than the 
expression of the same molecule by non-smokers’ PM, 
57.5 (35.C62.0)%, (PcO.05, Fig. 1). 
The expression of CD71 was lower in smokers, 68.0 
(64.0-71.5)%, compared with non-smokers, 91.5 (8O.c 
93.5)%, (P<O.Ol), whereas the expression of CD1 lb, CD68 
and RFD7 did not differ between the groups. 
Discussion 
In this study we wanted to investigate smoking-induced 
changes in the immunophenotype of macrophages in 
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FIG. 1. Percentage of PMs expressing HLA-DR, RFDI, 
CD54 and CD71 in non-smokers (0; n=7) and smokers 
(0; n=9). *p<o.o5; **p<o.o1. 
PLATE 1. Three-step immunocytochemical stain for HLA 
II on macrophages recovered with induced sputum. Posi- 
tivity shows as strong dark staining of the cytoplasm of 
the macrophages. 
induced sputum. The cell viability and total cell count did 
not differ between smokers and non-smokers. Smokers had 
a significantly higher percentage of macrophages in their 
sputum samples compared to non-smokers. This corre- 
sponds well to results shown earlier in BAL fluids (6,12). 
The increased number of macrophages in smokers’ BAL 
and sputum material could hypothetically depend on a 
decreased clearance of macrophages from the airways as 
well as an increased recruitment of blood monocytes to the 
alveoli. In contrast to previous findings in sputum from 
normal subjects (13-15) our non-smokers had somewhat 
high neutrophil counts. The reason for this is at present not 
obvious to us. 
The expression of different surface antigens on pulmon- 
ary macrophages is fundamental to their function as a vital 
part of the lung’s immune defence. Our immunocytological 
staining results showed a significantly decreased percentage 
of macrophages expressing the HLA II and HLA 
II-associated RFD 1 molecules in smokers. Using different 
immunofluorescence methods, Mancini et al. (11) and Pan- 
kow et al. (12) have reached similar results, showing a 
decrease in HLA-DR expression on smokers’ AM in BAL. 
Furthermore, we found a decreased percentage of PM 
expressing the adhesion molecule CD54 (ICAM-1) in smok- 
ers. Since the HLA II complex and the leukocyte adhesion 
molecules are vital in antigen presentation by macrophages, 
a decrease in expression of these molecules could, 
TABLE 2. Sputum cell count data in smokers and non-smokers (medians with upper and lower quartiles) 
Viability TCC Macrophages Lymphocytes Neutrophils Eosinophils 
n (%) ( x 106) cw (%I WI (%I 
Non-smokers 7 95.0 (89.0-97.0) 1.9 (1.3-3.2) 36.4 (26.7X+4)* 1.7 (0.7-2.7) 63.4 (49.7-66.4)* 0.7 (04-0.7) 
Smokers 9 90.0 (81.0-92.0) 1.9 (1.3-2.3) 69-4 (51.4-75.9) 1.0 (0.8-1.0) 29.6 (14.7-36.4) 0.7 (0.2-3.0) 
*p<o.o5. 
TABLE 3. Percentage of sputum macrophages expressing antigens as detected by monoclonal 
antibodies, using a three-step alkaline phosphatase immunocytochemical method (data are expressed 
as medians and interquartile ranges) 
Monoclonal Smokers 
antibodies (n=9) 
Non-smokers 
(n=7) Mann-Whitney U test 
RFD1 
RFD7 
CDllb 
CD54 
CD68 
CD71 
HLA DR 
57.0 (42G62.5) 
58.0 (50.0-65.0) 
52.0 (38.0-54.5) 
33.0 (14.043.0) 
42.0 (35.0-46.0) 
68.0 (64.0-71.5) 
93.0 (84.0-95.0) 
86.0 (76.0-89.0) 
68.0 (56.0-78.0) 
64.0 (42.0-67.0) 
57.5 (35.0-62.0) 
32.0 (28.0-36.0) 
91.5 (80.0-93.5) 
100 
P<O.Ol 
n.s. 
n.s. 
PCO.05 
ns. 
PXO.01 
PCO.01 
ns. =not significant. 
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hypothetically, give rise to a reduced antigen-presenting 
capacity. 
The expression of CD1 1 b did not differ between smokers 
and non-smokers. This is consistent with earlier studies of 
smoke exposure effects on AM in BAL fluid (16). 
We detected a lower expression of the transferrin recep- 
tor (CD71) in the smoking population. The expression of 
CD54, CD71 and RFD1 has been shown to correlate 
directly with the CD4/CD8 ratio and percentage of BAL 
lymphocytes in sarcoidosis (17). This disease is character- 
ized by an accumulation of CD4+ T lymphocytes in the 
alveoli and up-regulation of CD54 (18,19), CD71 (17,20) 
and RFD1 (17) on BAL macrophages. It has been sug- 
gested that alterations in the balance of signals from lung 
macrophages may be an important factor in enhanced 
CD4+ T-cell activity in sarcoidosis (21). The fact that 
smokers’ macrophages show a decreased expression of 
markers specifically up-regulated on macrophages in sar- 
coid patients could, hypothetically, offer one explanation 
for the lower incidence of sarcoidosis in the smoking 
population. 
When processing sputum according to the method used 
in this study, sputum plugs are not separated from saliva. 
The method of processing the whole expectorated sample 
guarantees that no material loss takes place during the 
processing, but it gives a varying percentage of squamous 
epithelial contamination in the sample. A large number of 
squamous cells can sometimes disturb the assessment 
of macrophages. This problem can be solved in the majority 
of cases by diluting the sample before producing cytospins. 
The ALP immunostain gives clearly detectable red stain in 
positive cells and allows, together with HTX counterstain, a 
good detection of morphological characteristics. When 
assessing the positivity, the observer graded the colouring 
as weak, moderate and strong stain and then established a 
limit below which cells were assessed as negative. For some 
markers the limit between positive and negative cells was 
difficult to determine. The samples were therefore assessed 
by two independent observers and a large number of cells 
were counted to avoid errors. 
In this study we have shown in sputum a smoking- 
induced change in cell proportions and expression of 
macrophage-specific antigens that has previously been 
demonstrated by several investigators in material recovered 
by BAL. BAL and IS do, however, provide the investigator 
with material deriving from different compartments in the 
lung. The origin of cells collected with BAL is mainly the 
alveoli. Cells recovered by sputum are more likely to derive 
from the proximal airways. Using airway lining fluid 
(ALF), which gives an opportunity to assess cells deriving 
from major airways selectively, Rankin et al. (22) have 
shown that viable macrophages reside in the airways and 
that they express similar surface and cytoplasmic antigens 
compared to macrophages recruited by BAL. 
Hypothetically, the phenotype of cells in induced sputum 
could correspond to the phenotypic patterns of cells recov- 
ered with BAL. Induced sputum could then, together with 
immunological methods, provide a possibility for repeat- 
edly sampling the pulmonary milieu and following 
dynamic, immunological processes in different pathological 
conditions. Further studies, comparing macrophages in 
sputum and BAL, are indicated. 
In conclusion, we found that chronic exposure to smoke 
changes the phenotype of macrophages retrieved by 
induced sputum. Smokers’ macrophages show a decreased 
expression of antigens that are up-regulated on macro- 
phages in sarcoidosis and important in the antigen- 
presenting process. The changed phenotype of pulmonary 
macrophages induced by chronic exposure to smoke could 
hypothetically explain the lower tendency to develop 
sarcoidosis in the smoking population. 
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